Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

NCT00508274 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
52
Enrollment
INDUSTRY
Sponsor class

Stopped Primary analysis was completed in 2015 and data collection post 1-Jul-2019 was not reportable due to local regulations in China.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals